Agilux Laboratories, Inc. is a privately held contract research organization (CRO) focused on bioanalytical and PK/PD testing services for the biotech and pharmaceutical industries. Leveraging industry and contract experience of its management team, the company delivers high quality bioanalytical chemistry and PK/PD data more rapidly.
Agilux helps clients make better decisions during drug discovery and development by providing quality data earlier in the research process by using technologies and systems that increase turnaround speed well beyond industry standards.
Founded in 2007 by industry experts Jim Jersey, Steve Guyan and Peter Glick, Agilux is headquartered in Worcester, MA and is funded by private equity firm, Ampersand Capital Partners.
She rated Agilux a 5 compared to the competition for which she is familiar. Agilux is quicker; better turn-around-times than others. Could be due to size of the company but knowing studies can be completed in a week is a big plus.